Subscribe to Newsletter

Content by Stephanie Vine:

 Manufacture Ingredients

Moving Away From “Quality by Fear”: Part II

| Stephanie Vine

Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.
Manufacture Ingredients

Moving Away From “Quality by Fear”: Part I

| Stephanie Vine

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.
Discovery & Development Technology and Equipment

The story behind an FDA-Approved Video Game Treatment for ADHD

| Stephanie Vine

We find out more about the video game that won FDA approval as a treatment for children with ADHD
Manufacture Contract Manufacturing Services

The Greener, Cleaner Path

| Stephanie Vine

We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.
Business & Regulation Business Practice

Teva Takes Hit in New York Opioid Case

| Stephanie Vine

After other defendants in the case settle, Teva is left to face the music in New York alone.
Manufacture Advanced Medicine

Can Cell Therapies Take on Solid Tumors?

| Stephanie Vine

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

Business & Regulation Contract Manufacturing Services

The New CDMO on the Block

| Stephanie Vine

Can ten23 health really make a difference to the planet while fully supporting its biopharma customers? We find out.
Business & Regulation Technology and Equipment

FDA Authorizes VR for Pain Reduction

| Stephanie Vine

AppliedVR gets FDA OK to market virtual reality system for chronic pain.
Discovery & Development COVID-19

Pharma Versus Omicron

| Stephanie Vine

How will vaccine and therapeutic makers respond to the new SARS-CoV-2 variant?
Business & Regulation Standards & Regulation

Will it Really Be Built Back Better?

| Stephanie Vine

A quick look at reactions across the US to Biden’s Build Back Better bill.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker